: Factor XIII Inhibitor, Plasma, Qualitative
: This test looks for an inhibitor (an antibody) in plasma that blocks the activity of factor XIII, a clotting protein that helps stabilize blood clots. Finding an inhibitor can help explain unusual or prolonged bleeding.
[": A factor XIII inhibitor test checks whether an antibody in your plasma is interfering with a clotting protein needed for stable clot formation."]
Key facts at a glance
- LOINC
- 3236-7
- Short code
- Fact XIII Inhib PPP-aCnc
- Synonyms
- Fact XIII Inhib PPP-aCnc
- Category
- chemistry
- Sample
- plasma
- Container
- Lavender-top (EDTA) or Green-top (Heparin)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- coag
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
: What This Test Measures
: Factor XIII is a protein that cross-links fibrin, the mesh that forms a blood clot, making the clot strong and durable. An inhibitor is an antibody that attaches to factor XIII and reduces its function. This test examines plasma to detect such an inhibitor qualitatively—meaning it reports whether an inhibitor appears to be present rather than giving an exact amount.
: Why Your Doctor May Order It
: This test is usually ordered when a person has a bleeding tendency that does not fit other common causes, or when factor XIII activity is low without a clear inherited reason. It may also be checked if a previously diagnosed factor XIII deficiency seems to behave unusually, which can happen when an acquired inhibitor is involved.
: How the Sample Is Collected
: A blood sample is drawn from a vein into a tube containing an anticoagulant, and the plasma is separated for testing. Tell your care team about any blood-thinning medications, recent transfusions, or bleeding episodes, since these can affect how results are interpreted.
: What Results Can Mean
: A result suggesting an inhibitor is present points toward an acquired factor XIII inhibitor, a condition that can cause serious bleeding and needs prompt medical attention. A result without evidence of an inhibitor is reassuring but is interpreted together with factor XIII activity levels and your symptoms. Because this is a specialized test, your doctor will explain what the finding means for your situation.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
: Acquired factor XIII inhibitors are rare but clinically important because they can cause severe, sometimes life-threatening bleeding and are treated differently from inherited factor deficiencies. This qualitative test supports diagnosis and monitoring but is not a standalone diagnosis; it is interpreted alongside factor XIII activity, mixing studies, and the clinical picture, and management should involve a hematologist.
Short name
: Factor XIII Inhibitor
Frequently asked questions
: Does a positive factor XIII inhibitor result mean I definitely have a bleeding disorder?
: Do I need to fast or change my medications before this test?
: Is this the same as a factor XIII activity level test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy